Sichuan Kelun Pharmaceutical: Regarding the advisory notice on the first release of the 2021 Restricted Stock Incentive Plan and the second unlocking period for restricted shares to be listed and traded.
Sichuan Kelun Pharmaceutical: Reminder announcement on the end of the second lockdown period of the 2021 Employee Stock Ownership Plan
Sichuan Kelun Pharmaceutical: Announcement on partial share pledges and cancellation of pledges by the controlling shareholder of the company
Sichuan Kelun Pharmaceutical: Announcement on the subsidiary's core product, lucan satuzumab (sAC-TMT), announcing research results at the 2024 American Society of Clinical Oncology Annual Meeting
Sichuan Kelun Pharmaceutical: 2023 dividend payment implementation announcement
Sichuan Kelun Pharmaceutical: Announcement of Resolutions of the First Meeting of the Eighth Board of Supervisors
Sichuan Kelun Pharmaceutical: Announcement on applying for liability insurance for company directors, supervisors and senior management
Sichuan Kelun Pharmaceutical: Announcement on the repurchase and cancellation of some restricted stocks in the 2021 Restricted Stock Incentive Plan
Sichuan Kelun Pharmaceutical: Announcement of the resolution of the first meeting of the 8th Board of Directors
Sichuan Kelun Pharmaceutical: Announcement on the achievements of the 2021 Restricted Stock Incentive Plan to lift the conditions for lifting the restrictions during the second period of the restricted sales period
Sichuan Kelun Pharmaceutical: Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on matters relating to the lifting of sales restrictions during the second period of the 2021 Restricted Stock Incentive Plan of Sichuan Kelun Pharmaceutical Co., Ltd.
Sichuan Kelun Pharmaceutical: Legal opinion on matters relating to the fulfillment of the conditions for lifting sales restrictions and the repurchase and cancellation of some restricted stocks in the 2021 Restricted Stock Incentive Plan of Sichuan Colon Pharmaceutical Co., Ltd.
Sichuan Kelun Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Sichuan Kelun Pharmaceutical: Legal Opinion of Colon Pharmaceuticals 2023 Annual General Meeting of Shareholders
Sichuan Kelun Pharmaceutical: May 13, 2024 Investor Relations Activity Schedule
Sichuan Kelun Pharmaceutical: Announcement on the results of the election of the company's employee representatives and supervisors for a new term
Sichuan Kelun Pharmaceutical: Announcement of Resolutions of the 37th Meeting of the Seventh Board of Directors
Sichuan Kelun Pharmaceutical: Announcement on the subscription for domestic shares issued by the holding subsidiary Collumbotai
Sichuan Kelun Pharmaceutical: Announcement on holding the 2023 online results briefing
Sichuan Kelun Pharmaceutical: Investor Relations Activity Schedule for April 25, 2024
No Data